Indinavir: Clinical Trials

98 trials of Indinavir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

86 completed, 5 unknown, 4 terminated, 2 withdrawn. 37 Phase 2, 28 Not applicable, 15 Phase 3, 12 Phase 1, 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 237Completed 30, Unknown 4, Suspended 1, Terminated 1, Withdrawn 1
Not applicable28Completed 24, Terminated 3, Withdrawn 1
Phase 315Completed 14, Unknown 1
Phase 112Completed 12
Phase 47Completed 7

Follow Indinavir: new trials by email Literature Review of Indinavir trials Research Report on Indinavir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy
triple therapy, dual therapy - HIV
Phase 3CompletedUniversity Hospital, Tours2242014-12-012025-12-26
Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma
Indinavir in association with Vinblastina +/- Bleomicina - Kaposi's Sarcoma
Phase 2CompletedBarbara Ensoli, MD, PhD252008-06-012016-08-30
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
indinavir sulfate, ritonavir, radiation therapy - Cancer
Phase 2UnknownOncology Institute of Southern Switzerland602007-09-012013-08-12
The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin
indinavir/ritonavir - HIV Infections, Tuberculosis
Phase 1 / Phase 2CompletedThe HIV Netherlands Australia Thailand Research Collaboration202006-12-012020-07-17
A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir
Indinavir/Ritonavir/Fosamprenavir - HIV Infections
Phase 4CompletedEmory University152005-07-012013-11-11
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Nevirapine, Efavirenz, Indinavir/ritonavir - HIV Infections
Phase 1CompletedGermans Trias i Pujol Hospital6752005-01-012019-12-04
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
atazanavir/cobicistat, darunavir/ritonavir dosage #1, darunavir/ritonavir dosage #2 - HIV Infections
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)15782003-06-092025-12-02
Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug Indinavir
indinavir - Classical Kaposi's Sarcoma
Phase 2CompletedIstituto Superiore di Sanità282003-06-012008-04-14
A Prospective Cohort of Children With HIV Infection
Zidovudine, Stavudine, Didanosine, Lamivudine, Nevirapine, Efavirenz, LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir - HIV Infections
CompletedThe HIV Netherlands Australia Thailand Research Collaboration5002003-03-012025-03-17
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
Lamivudine, Stavudine, Didanosine - HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease
Phase 4CompletedKirby Institute802003-02-012012-04-12
Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)
Structured Treatment Interruption, Zidovudine (ZDV), Lamivudine (3TC) - HIV Infections
Phase 3CompletedFrench National Agency for Research on AIDS and Viral Hepatitis8402002-12-012008-12-30
Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers
Midazolam, Indinavir, Saquinavir - Healthy, HIV Infections
Phase 4CompletedNational Institutes of Health Clinical Center (CC)812002-11-222017-07-02
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) - HIV Infections
Phase 2 / Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2662002-08-012021-11-05
Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)
nelfinavir, lopinavir/r, indinavir - HIV Infections
Not applicableTerminatedFrench National Agency for Research on AIDS and Viral Hepatitis1152002-07-012005-08-01
Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance
Indinavir, Lamivudine, Ritonavir - HIV Infections
Phase 2TerminatedFrench National Agency for Research on AIDS and Viral Hepatitis402002-02-012007-01-18
Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women
Indinavir sulfate, Ritonavir, Nelfinavir mesylate - HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)762001-06-012012-11-02
Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers
Indinavir sulfate, Ritonavir, Amprenavir - HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)902001-03-012021-11-01
A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
MK0639, indinavir sulfate / Duration of Treatment: 48 Weeks, Comparator: nelfinavir mesylate / Duration of Treatment: 48 Weeks - HIV Infections
Phase 2CompletedMerck Sharp & Dohme LLC3302001-01-012017-02-17
Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
Indinavir sulfate, Ritonavir, Delavirdine mesylate - HIV Infections
Not applicableTerminatedAgouron Pharmaceuticals602000-08-012005-06-24
Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs
Indinavir sulfate, Ritonavir, Stavudine - HIV Infections
Phase 3UnknownPPD Development, LP2002000-08-012005-06-24

Showing 20 of 98. Sign in to see all of them.

Conditions studied

HIV Infections (91)  ·  Acquired Immunodeficiency Syndrome (10)  ·  AIDS-Related Complex (3)  ·  Cardiovascular Diseases (2)  ·  Sarcoma, Kaposi (2)  ·  AIDS-related Kaposi sarcoma (1)  ·  Adenocarcinoma, Follicular (1)  ·  Adolescent Behavior (1)  ·  Adrenocortical Carcinoma (1)  ·  Anus Neoplasms (1)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (40)  ·  Merck Sharp & Dohme LLC (21)  ·  Glaxo Wellcome (7)  ·  Bristol-Myers Squibb (3)  ·  French National Agency for Research on AIDS and Viral Hepatitis (3)  ·  Pharmacia and Upjohn (3)  ·  Dupont Merck (2)  ·  National Cancer Institute (NCI) (2)  ·  The HIV Netherlands Australia Thailand Research Collaboration (2)  ·  Abbott (1)  ·  Agouron Pharmaceuticals (1)  ·  Barbara Ensoli, MD, PhD (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Emory University (1)  ·  Germans Trias i Pujol Hospital (1)

Countries

United States (81)  ·  Puerto Rico (22)  ·  Canada (6)  ·  France (3)  ·  Italy (3)  ·  Thailand (3)  ·  Australia (2)  ·  Spain (2)  ·  Tanzania (2)  ·  Argentina (1)  ·  Botswana (1)  ·  Brazil (1)  ·  Côte d’Ivoire (1)  ·  South Africa (1)  ·  Switzerland (1)

Top investigators

Scott Hammer (3)  ·  Collier A (2)  ·  Constance Benson (2)  ·  Fischl MA (2)  ·  Hammer SM (2)  ·  Richard Pollard (2)  ·  Ronald Mitsuyasu (2)  ·  Squires KE (2)  ·  Andrew D Carr, MD (1)  ·  Ann Collier (1)  ·  Ann J. Melvin, MD (1)  ·  Barbara Ensoli, MD, PhD (1)  ·  Benson CA (1)  ·  Bonaventura Clotet, MD, PhD (1)  ·  Brian Conway (1)

Results publications

PMID 24326304, PMID 10659875, PMID 11306155, PMID 11840078, PMID 11980557, PMID 12934177, PMID 14668455, PMID 14668456, PMID 14982784, PMID 15002082, PMID 15187476, PMID 15356820, PMID 15483465, PMID 15687448, PMID 15892437, PMID 15958837, PMID 16048950, PMID 16048984, PMID 16084849, PMID 16103764, PMID 16192247, PMID 16267764, PMID 16470119, PMID 16547789, PMID 16583266, PMID 16782488, PMID 16810109, PMID 16816555, PMID 16988514, PMID 17174704, PMID 17280617, PMID 17662759, PMID 17726714, PMID 18176329, PMID 18215978, PMID 18226670, PMID 18366444, PMID 18676758, PMID 18795962, PMID 18977721, PMID 18986246, PMID 18989231, PMID 20002783, PMID 20467286, PMID 20547574, PMID 20632458, PMID 20687947, PMID 21239359, PMID 21283017, PMID 21288774

NIH funding

2004 (1), R01HL065953 (1)